Harvard Business Review

APRIL 27, 2012

But he's not alone in the judgment that we're not actually living in an era of great innovation. but the emerging markets boom has generally been more about catching up than exploiting cutting-edge technology.). But the innovations Brynjolffson has been looking at are mostly organizational.

Stephenson 16

Stephenson Innovation Biotechnology eBook 16

Harvard Business Review

MARCH 11, 2014

That is, why bother trying to innovate if no matter what they do, large companies can no longer maintain a sustainable advantage and their life spans are just getting shorter and shorter? In these markets if existing companies don’t rise to the innovation challenge, no one will. “Why bother?”.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Harvard Business Review

MARCH 28, 2012

This ongoing struggle raises an issue that is endemic in such acquisitions: In search of innovation, big companies often buy other companies whose most innovative days are almost at an end. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

MAY 2, 2011

As multinational corporations pursue opportunities in emerging markets, they're bound to stumble if they overlook the developed economies, and vice versa. Nokia, for example, commanded market shares of 40% in China and 56% in India by 2008. Nokia, for example, commanded market shares of 40% in China and 56% in India by 2008.

Globalization 14

Globalization Marketing Venture Capitalist Biotechnology 14

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.

Globalization 10

Globalization Innovation Decentralization Chemicals 10

Harvard Business Review

OCTOBER 1, 2014

The implicit axiom here is that robust companies that have sustained and grown over the longer term are somehow less innovative. And Alibaba is a 16 year-old company, and no one is claiming it is sluggish or un-innovative.) But wait a minute – is starting more new businesses always a good thing?

Entrepreneur 12

Entrepreneur Biotechnology Real Estate Innovation 12

Harvard Business Review

JULY 11, 2018

However, young people are less common in other industries such as oil and gas or biotechnology, where the average age is closer to 47. Steve Jobs and Apple introduced the company’s most profitable innovation, the iPhone, when Jobs was 52. In software startups, the average age is 40, and younger founders aren’t uncommon.

Succession 15

Succession IPO Entrepreneur Biotechnology 15

Harvard Business Review

OCTOBER 26, 2011

Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Click on the table below to see at full size.).

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

MARCH 8, 2013

government, which through DARPA and other initiatives stands out worldwide for its astoundingly positive track record in funding true innovation. government is often portrayed as providing a safeguard against market failure. Yet it's a capitalism impossible to conceive of without the U.S. In a business context, the U.S. Consider Apple.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Innovation 8

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. Use Convergence Thinking.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. The Institute for Applied Cancer Science at MD Anderson (IACS) is exploring revolutionary new cures and the National Network for Manufacturing Innovation (NNMI) is working to revive the US production capacity. The Valley of Death.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Strategy Driven

NOVEMBER 18, 2019

This increased the need for care items for the elderly and there are plenty of gaps in the market for the healthcare sector. There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in. Technology.

Health Care 67

Health Care Biotechnology Energy Insurance 67

Harvard Business Review

OCTOBER 16, 2013

If we want to have a strong economy, we need to make sure we’re tilting the playing field in favor of entrepreneurs that are trying to challenge the status quo, innovate, create new products and services, disrupt existing industry, usher in a new way. Or Chipotle, $12 billion market value right now based in Denver.

Venture Capitalist 10

Venture Capitalist Company Biotechnology Transportation 10

Harvard Business Review

MARCH 13, 2012

And of course that's true — but the commodities market has been booming only in recent years, and the bank's track record is long and impressive. Is it possible that local funding could help bolster tourism in Florida, biotechnology in California, publishing in New York, and agriculture in Iowa?

Biotechnology 10

Biotechnology Real Estate Tourism Banking 10

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long. The options are tangible.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

The Horizons Tracker

DECEMBER 30, 2019

Location has always been vital for startups, both in terms of providing ready access to human capital to help develop the startup’s proposition, but also to provide ready access to a local market to help develop momentum. They raised more money and were acquired at higher valuations; however, they did not innovate more.

Biotechnology 56

Biotechnology Human Capital Travel Entrepreneur 56

Harvard Business Review

FEBRUARY 3, 2015

Make you more innovative. Uzzi and another colleague, Jarrett Spiro, also discovered that this pattern held across sectors as disparate as the Broadway mu­sical industry and biotechnology. The sidebar “The Innovator’s Network Dilemma” presents convincing data that bears out this observation. Start a blog.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

NOVEMBER 29, 2016

It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing. Innovating for Value in Health Care. Insight Center. Sponsored by Medtronic. Exploring cutting edge ways to lower costs and improve quality.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

MARCH 5, 2012

Thus, the decline of manufacturing is not completely a result of "natural" market forces. This tight connection between R&D, innovation, and production is present in sectors like biotechnology, advanced materials, and nanotechnology. There are some popular arguments for government action to revive manufacturing that I don't buy.

Health Care 9

Health Care Biotechnology Industry Policies 9

Harvard Business Review

SEPTEMBER 11, 2014

That means new technologies and new competitors are hitting the market at an unprecedented rate. If you’re in the upper right quadrant — or in the top 10 most uncertain industries as shown in the Table — you require greater innovation management skills than industries in the other quadrants or in the bottom 10.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JUNE 12, 2012

trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials. The United States is home to some of the key pioneers of Technik whose innovations help society adapt to the future. It pledges $1.5

First-mover Advantage 9

First-mover Advantage GDP Technology Biotechnology 9

Harvard Business Review

NOVEMBER 9, 2016

While it’s understandable that stock and currency markets would react this way to the outcome of the election, I believe that it’s somewhat of an overreaction. The price of steel is set in international markets and is subject to high cyclical variations. They supported world-class research and innovation locally.

Cooper 14

Cooper Long-term Industry Health Care 14